Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of JNJ-28431754 in patients with Type 2 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JNJ-28431754

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED